Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Yantai Yuhuangding Hospital

Clinical trials sponsored by Yantai Yuhuangding Hospital, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug duo aims to shrink aggressive breast cancer before surgery Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug duo aims to shrink aggressive breast cancer before surgery

Disease control Not yet recruiting

This phase 2 trial tests a combination of two drugs—sacituzumab tirumotecan and pembrolizumab—given before surgery to people with stage II or III triple-negative breast cancer. The goal is to see if the treatment can completely eliminate the cancer by the time of surgery. The stu…

Phase 2 • Sponsor: Yantai Yuhuangding Hospital • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC